Guardant Health Inc.

Guardant Health Inc. is a leading precision oncology company that specializes in developing and commercializing liquid biopsy tests for cancer diagnosis and treatment. Their proprietary technology, Guardant360, is a comprehensive genomic profiling test that analyzes circulating tumor DNA in the blood to identify cancer mutations and guide personalized treatment decisions. Guardant Health's liquid biopsy tests are non-invasive, cost-effective, and provide real-time results, making them an attractive alternative to traditional tissue biopsies. Their mission is to improve patient outcomes by providing oncologists with the tools they need to make more informed treatment decisions and accelerate the development of new cancer therapies. With headquarters in Redwood City, California, and operations in the United States, Europe, and Asia, Guardant Health is at the forefront of precision medicine.